Evidence map›Paper›PMID 25342326›Full record

ArticleJournal of cancer research and clinical oncology2015

MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation.

Xiushan Zheng, Jiaqiang Dong, Taiqian Gong, Zhiyong Zhang, Ying Wang, Yunming Li, Yulong Shang, Kai Li, Gui Ren, Bin Feng and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  8. microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  9. Article
  10. Article
  11. Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  12. Article
  13. Dysregulation of non-coding RNAs in gastric cancer.World journal of gastroenterology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Xiushan ZhengState Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032, China.
Jiaqiang Dong
Taiqian Gong
Zhiyong Zhang
Ying Wang
Yunming Li
Yulong Shang
Kai Li
Gui Ren
Bin Feng
Juntang Li
Qifei Tian
Shanhong Tang
Li Sun
Mengbin Li
Hongwei Zhang
Daiming Fan
Air Force Medical University · CNXijing Hospital · CNKunming General Hospital of Chengdu Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposesUncontrolled proliferation is a key characteristic of gastric carcinogenesis and the precise mechanisms underlying the altered proliferation behaviors of GC cells have not been clearly elucidated. miRNAs has been suggested to play a crucial role in the pathogenesis and development of various cancers. In the present study, we employed an impedance-based real-time cell electronic sensing (RT-CES) system to detect the effects of ectopically expressed miRNAs on GC cell proliferation.

methodsmiRNA mimics were transfected into gastric cancer cell line SGC7901 and the effect of individual miRNA on the proliferation rate of the cells was measured by the RT-CES system. The screening results were validated with qRT-PCR and miR-137 was selected for further research. The effects of ectopically expressed miR-137 on GC cell growth and cell cycle progress were measured using MTT assay and flow cytometry. The target gene of miR-137 was predicted using different bioinformatics tools and the direct interaction between miR-137 and the 3'-UTR was confirmed with a luciferase reporter assay. The in vivo effect of miR-137 on GC cell proliferation was examined with a tumor-bearing nude mouse model. The correlation between miR-137 expression and patients' prognosis was explored in a cohort of 38 patients. Prognosis was explored in a cohort of 38 patients.

resultsEctopic expression of miR-137 was sufficient to inhibit GC cell proliferation both in vitro and in vivo. Bioinformatics prediction and luciferase reporter assay revealed CDK6 as a target gene through which miR-137 exerted an inhibitory function. Moreover, miR-137 expression positively correlated with better prognosis.

conclusionOur data indicated an important regulatory role of miR-137 in GC cell proliferation and that it may be explored as a prognostic marker for GC.

Indexed as

Cell ProliferationAgedAnimalsApoptosisBlotting, WesternCell CycleCell Line, TumorCyclin-Dependent Kinase 6FemaleFlow CytometryGene Expression Regulation, NeoplasticHeterograftsHumansLymphatic MetastasisMaleMiceCDK6 protein, humanCyclin-Dependent Kinase 6MicroRNAsMIRN137 microRNA, human

Identifiers

PMID25342326
PMCPMC11823929
OpenAlexW1968231207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.